Pharmarise Holdings Corporation
Notice Regarding Receipt of Dividends from Consolidated Subsidiaries
Received 906 million yen in dividends from the consolidated subsidiary PharmaErase Co., Ltd. and two other subsidiaries. The dividends were decided by the subsidiary shareholders meeting on August 18, Reiwa 8 (2026), and the receipt date was August 19, Reiwa 8. No impact on the company’s annual standalone results or on consolidated earnings.
Key Figures
- Dividend amount: 906 百万円
- Payers: PharmaErase Co., Ltd., and two other companies
- Dividend resolution date: 令和８年８月18日
- Dividend receipt date: 令和８年８月19日
AI要約
Dividend overview
We announce that we received a total of 906 million yen in dividends from consolidated subsidiaries PharmaErase Co., Ltd. and two other companies. The dividend resolution date was August 18, Reiwa 8, when the subsidiary shareholders meeting was held, and the receipt date is August 19, same year. Since the dividend comes from consolidated subsidiaries, it does not affect our earnings (consolidated).
Impact on earnings
In the May quarter for Reiwa 9, the dividend will be recorded as operating revenue in the standalone financial statements. The impact on consolidated earnings is stated as none.
Pharamarize Holdings Co., Ltd.
Company overview · Stock price · Financial data · All IR
